Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the…
DEA FACES FOUR FEDERAL DISTRICT COURT SUITS CLAIMING DISARRAY and CONSTITUTIONAL VIOLATIONS WASHINGTON, D.C. / ACCESSWIRE / May 13, 2024…
Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024US$9M growth capital secured in May strengthens financial position for…
Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on…
Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underwaySALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, the leader in specialized phototherapy for…
Partnership to enable cancer care centers to improve access and efficiency of clinical studies and researchNEW YORK--(BUSINESS WIRE)--Flatiron Health, a…
BOSTON--(BUSINESS WIRE)--Empatica, a pioneer in digital biomarker development and patient monitoring driven by AI, and McRoberts, one of the leaders…
STONY BROOK, NY / ACCESSWIRE / May 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…
UK submission for national MAA review follows recently received positive opinion from Committee for Medicinal Products for Human Use (CHMP)…